Skip Navigation


Hum. Reprod. Advance Access originally published online on November 11, 2004
Human Reproduction 2005 20(2):373-381; doi:10.1093/humrep/deh609
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/2/373    most recent
deh609v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rice, S.
Right arrow Articles by Franks, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rice, S.
Right arrow Articles by Franks, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction vol. 20 no. 2 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries

S. Rice1,4, N. Christoforidis2, C. Gadd2, D. Nikolaou2, L. Seyani3, A. Donaldson3, R. Margara2, K. Hardy1 and S. Franks1,5

1 Institute of Reproductive and Developmental Biology, 2 Department of Obstetrics and Gynaecology, Imperial College London, London and 3 Clinical Chemistry Laboratory, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK

5 To whom correspondence should be addressed. Email: s.franks{at}imperial.ac.uk

BACKGROUND: Insulin resistance and hyperinsulinaemia are well-recognized characteristics of anovulatory women with polycystic ovary syndrome (PCOS) but, paradoxically, steroidogenesis by PCOS granulosa cells remains responsive to insulin. The hypothesis to be tested in this study is that insulin resistance in the ovary is confined to the metabolic effects of insulin (i.e. glucose uptake and metabolism), whereas the steroidogenic action of insulin remains intact. METHODS: Granulosa-lutein cells were obtained during IVF cycles from seven women with normal ovaries, six ovulatory women with PCO (ovPCO) and seven anovulatory women with PCO (anovPCO). Mean body mass index was in the normal range in all three groups. Granulosa-lutein cells were cultured with insulin (1, 10, 100 and 1000 ng/ml) and LH (1, 2.5 and 5 ng/ml). Media were sampled at 24 and 48 h and analysed for glucose uptake, lactate production and (48 h only) progesterone production. RESULTS: Insulin-stimulated glucose uptake by cells from anovPCO was attenuated at higher doses of insulin (100 and 1000 ng/ml) compared with that by cells from either ovPCO (P=0.02) or controls (P=0.02). Insulin and LH stimulated lactate production in a dose-dependent manner, but insulin-dependent lactate production was markedly impaired in granulosa-lutein cells from anovPCO compared with either normal (P=0.002) or ovPCO (P<0.0001). By contrast, there was no difference in insulin-stimulated progesterone production between granulosa-lutein cells from the three ovarian types. CONCLUSIONS: Granulosa-lutein cells from women with anovPCOS are relatively resistant to the effects of insulin-stimulated glucose uptake and utilization compared with those from normal and ovPCO, whilst maintaining normal steroidogenic output in response to physiological doses of insulin. These studies support the probability of a post-receptor, signalling pathway-specific impairment of insulin action in PCOS.

Key words: granulosa cells/insulin resistance/LH/polycystic ovaries/progesterone

4 Present address: Department of Basic Medical Sciences, St George's Hospital Medical School, Cranmer Terrace, Tooting, London SW17 0RE, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr.
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
Endocr. Rev., February 1, 2009; 30(1): 1 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. C. Richardson, S. Ingamells, C. D. Simonis, I. T. Cameron, R. Sreekumar, A. Vijendren, L. Sellahewa, S. Coakley, and C. D. Byrne
Stimulation of Lactate Production in Human Granulosa Cells by Metformin and Potential Involvement of Adenosine 5' Monophosphate-Activated Protein Kinase
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 670 - 677.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Kenigsberg, Y. Bentov, V. Chalifa-Caspi, G. Potashnik, R. Ofir, and O. S. Birk
Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients
Mol. Hum. Reprod., February 1, 2009; 15(2): 89 - 103.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Dorfman, V. D. Ramirez, E. Stener-Victorin, and H. E. Lara
Chronic-Intermittent Cold Stress in Rats Induces Selective Ovarian Insulin Resistance
Biol Reprod, February 1, 2009; 80(2): 264 - 271.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Franks, J. Stark, and K. Hardy
Follicle dynamics and anovulation in polycystic ovary syndrome
Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R. A Forsdike, K. Hardy, L. Bull, J. Stark, L. J Webber, S. Stubbs, J. E Robinson, and S. Franks
Disordered follicle development in ovaries of prenatally androgenized ewes
J. Endocrinol., February 1, 2007; 192(2): 421 - 428.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Poretsky
Polycystic Ovary Syndrome--Increased or Preserved Ovarian Sensitivity to Insulin?
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2859 - 2860.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. C. Foong, D. H. Abbott, M. A. Zschunke, T. G. Lesnick, J. L. Phy, and D. A. Dumesic
Follicle Luteinization in Hyperandrogenic Follicles of Polycystic Ovary Syndrome Patients Undergoing Gonadotropin Therapy for in Vitro Fertilization
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2327 - 2333.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Palomba, A. Falbo, F. Orio Jr, F. Manguso, T. Russo, A. Tolino, C. Annamaria, B. Dale, and F. Zullo
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination
Hum. Reprod., October 1, 2005; 20(10): 2879 - 2886.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D.H. Abbott, D.K. Barnett, C.M. Bruns, and D.A. Dumesic
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
Hum. Reprod. Update, July 1, 2005; 11(4): 357 - 374.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.